SEMINAR: The many paths to therapy resistance in melanoma

Dr Meenhard Herlyn is a Caspar Wistar Professor of Melanoma Research and the Director of the Melanoma Research Center at The Wistar Institute in Philadelphia, and Founding President of the Society for Melanoma Research. He has been a cancer researcher since arriving at Wistar in 1976 and has worked in melanoma research since 1977. Leading two program projects, his current research focuses on the biological significance of stem cells in skin morphogenesis, and transformation, invasion, and metastasis using various in vitro and in vivo models. He has over 450 peer-reviewed publications, over 80% of which are on melanoma, while others address basic biological mechanisms in cancer. His current major efforts are developing novel therapeutic strategies that consider genetic and biologic signatures of melanomas.